International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-4 doi: 10.5281/zenodo.8121185
Original Article
A Prospective Study to Compare Intensity Modulated Radiation Therapy (IMRT) Planning by Flattening Filter (FF) versus Flattening Filter free(FFF) beam in Carcinoma Esophagus
 ,
 ,
 ,
 ,
 ,
 ,
 ,
 ,
 ,
Published
July 6, 2023
Abstract

Background: Esophageal cancer was previously treated with 3-dimensional conformal radiation therapy (3D-CRT). In order to benefit from the clinical potential of preserving the lung and spinal cord, radiation therapy for esophageal cancer has switched from 3D-CRT to intensity-modulated-radiation-therapy (IMRT).

Aim: It is important to investigate whether esophageal cancer radiotherapy employing flattening filter-free compared to flattened beams has any advantages. The goal of this study is to extensively compare the dosimetric features, delivery effectiveness (response), and toxicity of a treatment regimen for esophageal cancer of Flattening Filter (FF) and Flattening Filter Free (FFF) photon beams using Intensity Modulated Radiation Therapy (IMRT) technology.

Material and Methods: The present study was conducted as a prospective observational study on 60 patients with esophageal cancer undergoing radiation in Department of Radiation oncology, Govt. Medical College of Central India and associated Hospital. All 60 participants were randomly assigned into either of the two treatment group (IMRT-FF and IMRT-FFF) and were compared for dose volume histogram, toxicities and response.

Results: Two groups were comparable with respect to baseline variables and tumor characteristics (p>0.05). Mean and maximum heart dose; minimum, maximum as well as mean dose of left lung; minimum and maximum dose of right lung and minimum and mean dose in spinal cord in IMRT-FF group were significantly higher in IMRT-FF group as compared to IMRT-FFF group (p<0.05). The response was significantly better in FFF group (p<0.05). We found no significant difference in toxicities to organ at risk between two treatment arm (p>0.05).

Conclusion: IMRT FF and IMRT FFF are standard photon beam used for management of patients with esophageal cancers. FFF photon beam in comparison to FF photon beam provides better OAR sparing by less scattered dose, improves quality of life and runs treatment process smoothly. The most beneficial character of FFF beam plan is clinically desirable and physically acceptable treatment plan at lower dose for target coverage and reduction of peripheral dose around target without compromising quality of beam.

Recommended Articles
Loading Image...
Volume-4, Issue-4
Citations
1069 Views
250 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved